Stay updated on BXCL701 in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the BXCL701 in Pancreatic Cancer Clinical Trial page.

Latest updates to the BXCL701 in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 replaces the prior v3.3.1 on the page header/footer. This is a metadata update with no impact on the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.3.1 was added and the previous Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding/status notice banner from the ClinicalTrials.gov page; no other study details were altered, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedCore trial information such as title, conditions, eligibility criteria, endpoints, and status remained unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check79 days agoChange Detected- Added PT-100 dipeptide and updated the revision to v3.1.0. - Removed talabostat and the older revision v3.0.2. Overall, the page updates reflect an updated product lineup and newer versioning, replacing the old item and version.SummaryDifference0.2%

Stay in the know with updates to BXCL701 in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BXCL701 in Pancreatic Cancer Clinical Trial page.